Scleroderma renal crisis: pathogenesis issues, disease pattern and modern approaches to the treatment
Journal Title: Нирки - Year 2018, Vol 7, Issue 4
Abstract
Scleroderma renal crisis (SRC) is a major complication in patients with systemic sclerosis. SRC occurs in about 5–25 % of all patients with scleroderma. It is characterized by malignant hypertension and olig-/anuric acute renal failure. Around 10 % of SRC cases may present with normal blood pressure, termed normotensive renal crisis. The etiopathogenesis is presumed to be a series of insults to the kidneys resulting in endothelial injury, intimal proliferation, and narrowing of renal arterioles leading to decreased blood flow, hyperplasia of the juxtaglomerular apparatus, hyperreninemia, and accelerated hypertension. SRC is often triggered by nephrotoxic drugs and/or intravascular volume depletion. SRC occurs particularly in the first years of disease and in its diffuse form. The occurrence of SRC is more common in patients treated with glucocorticoids, the risk increases with increasing dose. Left ventricular insufficiency and hypertensive encephalopathy are typical clinical features. Thrombotic microangiopathy is detected in 43 % of the cases. Anti-RNA-polymerase III antibodies are present in one third of patients who develop SRC. Renal biopsy is not necessary if SRC presents with classical features. However, it can help to establish prognosis and approaches to the treatment in atypical forms. The prognosis of SRC has dramatically improved with the introduction of angiotensin-converting enzyme inhibitors. However, 5-year survival in patients with systemic sclerosis who develop the full picture of SRC remains low (65 %). The treatment of SRC is based on aggressive control of blood pressure with angiotensin-converting enzyme inhibitors, if needed, in combination with other types of antihypertensive drugs. Dialysis is frequently indicated, but can be stopped in approximately half of patients, mainly in those with good control of blood pressure. Patients who need dialysis for more than 2 years qualify for renal transplantation. SRC still remains an important cause of morbidity and mortality in scleroderma. Prompt diagnosis and treatment may help prevent adverse outcomes and improve survival.
Authors and Affiliations
I. Yu. Golovach, Ye. D. Yehudina
Keywords
Related Articles
- EP ID EP421443
- DOI 10.22141/2307-1257.7.4.2018.148521
- Views 72
- Downloads 0
Example of Renoprotective Therapy in Pediatric Nephrology: a Clinical Case
The article presents a clinical case of chronic kidney disease and chronic renal failure in a child with perinatal hypoxia and acute renal failure on the background of renal vein thrombosis in the early neonatal period,...
Diagnostic role of radionuclide methods in patients with pyelonephritis
Acute and chronic forms of pyelonephritis are the most common diseases of the urinary system in all age groups. The incidence rate of acute pyelonephritis in children is 19.1 per 1000, chronic pyelonephritis — 5–12.5 per...
Acute Glomerulonephritis: Clinical and Pathologic Features (Case Report)
Clinical observation demonstrates the case of acute postinfectious glomerulonephritis with its histopathological features with the preexisting injury of renal tubules — cystic kidney disease of undefined type. The patien...
Renal Parenchymal Hypoxia in Young Children in the Period of Complete Remission of Acute Uncomplicated Pyelonephritis without Renal Impairment
Introduction. After establishing the diagnosis of pyelonephritis, there is a need to determine, whether renal parenchymal hypoxia remains in the period of remission. The least studied methods up to now are functional one...
National Guidelines «Acute Kidney Injury: Basic Principles of the Diagnosis, Prevention and Treatment (2015)» Part II
The main problems of acute kidney injury (AKI) are considered. The necessity of introduction of the AKI concept into the practice of national health care is justified. Specific recommendations for the diagnosis, monitori...